TargetMol

Atopaxar hydrochloride

Product Code:
 
TAR-T1986L2
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1986L2-5mg5mg£1,412.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1986L2-50mg50mg£2,785.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1986L2-100mg100mg£3,765.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Atopaxar hydrochloride is used in the Treatment of Cardiovascular Disorders.
CAS:
474544-83-7
Formula:
C29H39BrFN3O5
Molecular Weight:
608.55
Purity:
0.98
SMILES:
COC1=C(N2CCOCC2)C=C(C(CN(CC3=C4C(F)=C(OCC)C(OCC)=C3)C4=N)=O)C=C1C(C)(C)C.[H]Br

References

1. Klonaris C, Patelis N, Drebes A, Matheiken S, Liakakos T. Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents. Curr Pharm Des. 2016;22(29):4610-4616. Review. PubMed PMID: 27281329. 2. Packard KA, Campbell JA, Knezevich JT, Davis EM. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome. Pharmacotherapy. 2012 Mar;32(3):244-73. doi: 10.1002/j.1875-9114.2012.01021.x. Review. PubMed PMID: 22392457. 3. Siddique A, Butt M, Shantsila E, Lip GY. New antiplatelet drugs: beyond aspirin and clopidogrel. Int J Clin Pract. 2009 May;63(5):776-89. doi: 10.1111/j.1742-1241.2009.02058.x. Review. PubMed PMID: 19392926. 4. Postu?a M, Akram S, Akram F. Current problems, new opportunities and future directions of anti-platelet therapy - increasing role of novel antiplatelet agents in cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2009 Jan;4(1):55-60. Review. PubMed PMID: 19149707.